PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Analysis compares stent expansion achieved with guidance from OCT versus IVUS

Findings from the ILUMIEN II trial presented at EuroPCR 2015

2015-05-20
(Press-News.org) Paris, France - May 20, 2015 - Data from the ILUMIEN II trial found that guidance from optimal coherence tomography (OCT) was associated with comparable stent expansion as guidance from intravascular ultrasound (IVUS) in patients undergoing percutaneous coronary intervention (PCI). Results from the study were presented today at EuroPCR 2015, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.

Coronary stents must be optimally deployed with full lesion coverage and complete stent expansion to optimize outcomes. Less than full expansion can result in stent thrombosis or restenosis. Previous studies have found that the strongest predictor of stent thrombosis and restenosis is the minimum stent area (MSA) achieved after PCI.

Advanced imaging techniques, such as IVUS and OCT, help cardiologists to measure, place, and expand the stent with optimal precision. By achieving greater stent luminal dimensions, IVUS-guidance has been associated with improved event-free survival compared to angiographic guidance alone. Compared to IVUS, OCT has superior resolution but does not penetrate as deeply into the arterial wall. Consequently it has limitations in assessing the true diameter of the native artery. It is unknown whether stent expansion, a surrogate of clinical outcomes, is as great with OCT-guidance as with IVUS-guidance.

ILUMIEN II was a prospectively planned, retrospective comparison of OCT-guidance in ILUMIEN I and IVUS-guidance in ADAPT-DES. The overall study population initially included a total of 940 patients (one lesion randomly chosen per patient; 354 from ILUMIEN I and 586 from ADAPT-DES). After 1:1 propensity matching, 286 patients/lesions from each group were analyzed (n=572).Both the OCT and IVUS analyses were performed by the CRF Clinical Trials Center.

The primary endpoint was post-PCI stent expansion (%) defined as the minimum stent area (MSA) divided by the mean reference lumen area as assessed by OCT in ILUMIEN I and by IVUS in ADAPT-DES. The secondary endpoints were the following IVUS and OCT core lab measures: -Mean stent expansion (defined as stent volume/stent length divided by the mean reference lumen area) -Prevalence of major edge dissection (3 mm in length) -Prevalence of major stent malapposition (malapposition distance/luminal diameter 20%) The secondary endpoint using angiographic core lab measures (independent of technique) was post-PCI mean lumen diameter (MLD), percent diameter stenosis, and acute gain.

The post-PCI stent expansion was 72.8% [63.3, 81.3] in the OCT-guided group compared to 70.6% [62.3, 78.8] in the IVUS-guided group (p=0.29). Similar rates of major stent edge dissection (2.4% vs. 1.0%, p=0.29) and major stent malapposition (1.4% vs. 0.7%, p=0.69) occurred in both groups.

"In this comparison of patients undergoing OCT-guided stenting from ILUMIEN I and IVUS-guided stenting from ADAPT-DES, OCT-guidance was associated with comparable stent expansion, slightly greater in-segment percent diameter stenosis, and similar rates of major stent malapposition, tissue protrusion, and stent edge dissection as IVUS-guidance," said Gregg W. Stone, MD, the lead investigator. Dr. Stone is Co-Director of CRF's Medical Research and Education Division. He is also Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center.

"Because this was a retrospective comparison from two separate study databases, with different patients, sites, and operators, additional research is needed to confirm these findings. The results of angiography-guided, IVUS-guided and OCT-guided stent implantation are currently being evaluated in a prospective, multicenter randomized trial - ILUMIEN III: OPTIMIZE PCI."

INFORMATION:

The ILUMIEN II trial was sponsored by St. Jude Medical. Dr. Stone reported no disclosures.

About CRF The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with heart disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. For more information, visit http://www.crf.org.



ELSE PRESS RELEASES FROM THIS DATE:

Online safety: If you want something done right, do it yourself

2015-05-20
When it comes to keeping online information safe from hackers and other criminals, it's up to the individual user to keep his or her data secure. Unfortunately, many Internet users don't take that responsibility seriously, thinking that's the job of the Internet provider or even the company that manufactured their computer. The end-user is often the "weakest link" in the Internet safety chain, said Saleem Alhabash, a Michigan State University faculty member who is part of a team that researches ways of making the Web safer for its users. The team's conclusion: Internet ...

Common mutation linked to heart disease

2015-05-20
A common mutation in a gene that regulates cholesterol levels may raise the risk of heart disease in carriers, according to a new UConn Health study. Researchers examined a mutation called the missense rs4238001 variant, which alters the type of protein made by the gene SCARB1, and thereby the body's cholesterol regulation. The study, led by Annabelle Rodriguez-Oquendo, an endocrinologist at UConn Health, was based on information about more than 5,000 people who participated in the Multi-Ethnic Study of Artherosclerosis in major American cities from 2000 to 2002. ...

Paleontologists discover the first dinosaur fossil in Washington State

Paleontologists discover the first dinosaur fossil in Washington State
2015-05-20
The fossils of the first dinosaur fossil from Washington State were collected along the shores of Sucia Island State Park in the San Juan Islands, and described in a study published May 20, 2015 in the open-access journal PLOS ONE by Brandon Peecook and Christian Sidor from the Burke Museum of Natural History and Culture at the University of Washington. The fossils were discovered while collecting ammonite fossils (a nautilus-like creature) from a marine rock unit known as the Cedar District Formation. The authors of the study describe the fossil as the partial left ...

Burke Museum paleontologists discover the first dinosaur fossil in Washington state

Burke Museum paleontologists discover the first dinosaur fossil in Washington state
2015-05-20
Burke Museum paleontologists have published a description of the first dinosaur fossil from Washington state. The fossil was collected by a Burke Museum research team along the shores of Sucia Island State Park in the San Juan Islands. Burke Museum researchers discovered the fossil while collecting ammonite fossils (a creature with a spiral shell) from a marine rock unit known as the Cedar District Formation. The researchers first noticed a small section of exposed bone on the surface of the rocks, then returned with a team of paleontologists to help excavate the fossil ...

Paracetamol in pregnancy may lower testosterone in unborn boys

2015-05-20
Prolonged paracetamol use by pregnant women may reduce testosterone production in unborn baby boys, research has found. Researchers say their findings could help to explain reported links between paracetamol use in pregnancy and reproductive health problems in young boys. Paracetamol is the primary medicine used for managing pain and fever during pregnancy. The authors recommend that expectant mothers should follow existing guidelines that the painkiller be taken at the lowest effective dose for the shortest possible time. Testosterone, produced in the testicles, ...

Public not being informed about dangers of medical overdiagnosis

2015-05-20
A national survey reveals that only one in ten Australians report being told about the risk of overdiagnosis by their doctors, according to research published today in the scientific journal PLOS ONE. The increasingly recognised problem of overdiagnosis happens when someone is diagnosed with a disease that will never cause them any harm, often as a result of healthy people being screened for diseases such as breast or prostate cancer. Overdiagnosis can be harmful due to unnecessary labelling and treatment. The telephone survey (mobile and landline) of 500 Australians ...

American College of Cardiology registry aims to improve cardiovascular care in India

2015-05-20
WASHINGTON (May 20, 2015) - Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association. Researchers used the American College of Cardiology's PINNACLE India Quality Improvement Program registry to examine performance measures and outline areas for further improvement in cardiovascular care delivery. There is a growing burden of cardiovascular disease in India, but only limited data is available ...

Re-engineered antibiotic shows potential for treatment of drug-resistant bacteria

2015-05-20
(MEMPHIS, Tenn. - May 20, 2015) Researchers led by St. Jude Children's Research Hospital scientists have developed a second-generation antibiotic that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. The findings appear today in the scientific journal Science Translational Medicine. The study marks the second time in recent years that St. Jude researchers have created promising antibiotics by changing the chemical structure of an old antibiotic named spectinomycin. Spectinomycin is a safe, but weak ...

New music strategy shows 70 per cent increase in exercise adherence

2015-05-20
TORONTO, May 20, 2015 - The use of personalized music playlists with tempo-pace synchronization increases adherence to cardiac rehab by almost 70 per cent--according to a study published in Sports Medicine -Open. "Cardiac rehab has been proven to improve long-term survival for someone who's had a heart event by 20 per cent," said Dr. David Alter, Senior Scientist, Toronto Rehab, University Health Network, and Institute for Clinical Evaluative Sciences. "Our challenge is there is a high drop-out rate for these programs and suboptimal adherence to the self-management of ...

New studies contradict earlier findings on Rett syndrome

2015-05-20
Independent reproduction of other scientists' results is a cornerstone of solid research, but scientists are rarely recognized for successfully reproducing published findings, much less for demonstrating that scientific findings cannot be reproduced. However, failure to reproduce a finding may suggest doubt about the robustness of the original work, which carries implications for anyone looking to build on those findings. University of Iowa neuroscientist Andrew Pieper unexpectedly found himself in the position of contradicting seemingly promising results published in ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Analysis compares stent expansion achieved with guidance from OCT versus IVUS
Findings from the ILUMIEN II trial presented at EuroPCR 2015